The trading price of Clover Health Investments, Corp. (NASDAQ:CLOV) floating lower at last check on Tuesday, Feb 23, closing at $11.08, -5.32% lower than its previous close.
Traders who pay close attention to intraday price movement should know that it has been fluctuating between $9.68 and $10.88. The company’s P/E ratio in the trailing 12-month period was 0, while its 5Y monthly beta was 0. In examining the 52-week price action we see that the stock hit a 52-week high of $17.45 and a 52-week low of $9.87. Over the past month, the stock has suffered -18.47% in value.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned CLOV a recommendation rating is 3. Out of them, 1 rate it a Hold, while 2 recommend Buy, whereas none assign an Outperform rating. None analyst(s) have tagged Clover Health Investments, Corp. (CLOV) as Underperform, while not any of them advise Sell. Analysts have rated the stock Overweight, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
If we dig deeper into the stock’s outlook, we see that the stock’s PEG is 0, which symbolizes a positive outlook. A quick review shows that CLOV’s price is currently -18.26% off the SMA20 and -21.88% off the SMA50. The RSI metric on the 14-day chart is currently showing 33.65, and weekly volatility stands at 6.43%. When measured over the past 30 days, the indicator reaches 8.74%. Clover Health Investments, Corp. (NASDAQ:CLOV)’s beta value is currently sitting at 0, while the Average True Range indicator is currently displaying 1.02. With analysts defining $15-$19 as the low and high price targets, we arrive at a consensus price target of $16.67 for the trailing 12-month period. The current price is about 42.99% off the estimated low and 81.12% off the forecast high, based on this estimate. Investors will be thrilled if CLOV’s share price rises to $16, which is the median consensus price. At that level, CLOV’s share price would be +52.53% above current price.
To see how Clover Health Investments, Corp. stock has been performing today in comparison to its peers in the industry, here are the numbers: CLOV stock’s performance was -5.32% at last check in today’s session, and 0% in the past year, while Cerner Corp (CERN) has been trading -0.34% in recent session and positioned -6.78% lower than it was a year ago. Another comparable company 10X Genomics Inc (TXG) saw its stock trading -0.09% lower in today’s session but was up +117.93% in a year. Furthermore, Invitae Corp (NVTA) showed a decline of -5.32% today while its price kept declining at 0% over the past year. Clover Health Investments, Corp. has a P/E ratio of 0, compared to Cerner Corp’s 27.73 and 10X Genomics Inc’s 0. Also during today’s trading, the S&P 500 Index has soared -0.49%, while the Dow Jones Industrial also saw a negative seesion, down -0.27% today.
An evaluation of the daily trading volume of Clover Health Investments, Corp. (NASDAQ:CLOV) indicates that the 3-month average is 14.97 Million. However, this figure has increased over the past 10 days to an average of 15.18 Million.